← back to search

Jiaqian Li

The First People's Hospital of Guiyang · CN
Area of research
Immunology · Immunology and Allergy
Research interest
Research interests include Cell Adhesion Molecules Research, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Immune cells in cancer, and Immune Cell Function and Interaction.
h-index
14
citations
2,853
works
30
NIH funding
primary concept
Biology
email

Recent publications

Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation
Nature Communications 2023cited by 71position: middledoi
Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition
Nature Cancer 2022cited by 81position: middledoi
CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition
Cancer Cell 2022cited by 58position: middledoi
Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer
Nature Immunology 2021cited by 119position: middledoi
Eosinophil extracellular traps drive asthma progression through neuro-immune signals
Nature Cell Biology 2021cited by 116position: middledoi
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer
Nature Cancer 2021cited by 57position: middledoi
DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
Nature 2020cited by 940position: middledoi
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output
Cell 2020cited by 459position: middledoi
Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity
Cell 2020cited by 278position: middledoi
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
Nature Immunology 2018cited by 469position: middledoi
Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine–Paracrine Loop
Clinical Cancer Research 2018cited by 95position: middledoi
Distinct Changes of BTLA and HVEM Expressions in Circulating CD4<sup>+</sup> and CD8<sup>+</sup> T Cells in Hepatocellular Carcinoma Patients
Journal of Immunology Research 2018cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shicheng Su · First Affiliated Hospital of Zhengzhou University8 papers (2018–2023)Erwei Song · Southern Medical University4 papers (2018–2021)Linbin Yang · Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital4 papers (2018–2021)Yue Xing · Fujian Special Equipment Inspection Institute4 papers (2018–2022)Yiwen Lu · Florida College4 papers (2018–2022)Boxuan Zhou · Nanchang University4 papers (2020–2023)Qi‐Dong Xia · Tongji Hospital3 papers (2020–2022)Di Huang · Fu Wai Hospital3 papers (2018–2021)Qiyi Zhao · Sun Yat-sen University3 papers (2018–2023)Jian‐You Liao · Chaoyang University of Technology3 papers (2020–2023)Qiang Liu · Stanford University3 papers (2018–2021)Qian Ouyang · Jiangxi Provincial Children's Hospital2 papers (2018–2021)Ruiying Ma · Korea University2 papers (2020–2023)Min Huang · Luohe Medical College2 papers (2018–2022)Qiyi Zhao · Sun Yat-sen University2 papers (2020–2021)Huixin Liang · Fujian Medical University2 papers (2020–2023)Jingwei Feng · University of Toledo2 papers (2021–2022)Yuanting Gu · First Affiliated Hospital of Zhengzhou University2 papers (2022–2023)Jingying Huang · Hebei Medical University2 papers (2021–2022)Liling Zhu · Sun Yat-sen Memorial Hospital2 papers (2022–2023)